{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Tien D"],"funding":["NIDDK NIH HHS","NIAID NIH HHS"],"pubmed_abstract":["<h4>Background</h4>People with HIV (PWH) have experienced excess weight gain on tenofovir, lamivudine, and dolutegravir (TLD). The contribution of lifestyle behavior to this weight gain is poorly understood.<h4>Methods</h4>The Population Effectiveness of Dolutegravir Implementation in sub-Saharan Africa (DISCO Study) was a prospective observational cohort study that followed participants in KwaZulu-Natal, South Africa, transitioning to TLD. Our primary outcome of interest was clinically significant weight gain, defined as ≥10% increase from baseline to 48 weeks. Primary exposures of interest were (1) fruit intake (servings/week), (2) vegetable intake (servings/week), (3) fast food intake frequency, (4) fried food intake frequency, (5) sugar-sweetened beverage (SSB) intake frequency, and (6"],"journal":["Journal of acquired immune deficiency syndromes (1999)"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12924645"],"repository":["biostudies-literature"],"pubmed_title":["Dolutegravir-based therapy, diet, physical activity and weight gain: a 48-week prospective cohort in South Africa."],"pmcid":["PMC12924645"],"funding_grant_id":["K23 AI143470","K23 DK125162","P30 AI050409"],"pubmed_authors":["Pillay D","Chandiwana N","Manne-Goehler J","Hedt-Gauthier B","Chen G","Siedner MJ","Tien D","Shazi G","Gupta RK","Moosa MS","McCluskey SM","Marconi VC","Venter WDF","Mabweazara S"],"additional_accession":[]},"is_claimable":false,"name":"Dolutegravir-based therapy, diet, physical activity and weight gain: a 48-week prospective cohort in South Africa.","description":"<h4>Background</h4>People with HIV (PWH) have experienced excess weight gain on tenofovir, lamivudine, and dolutegravir (TLD). The contribution of lifestyle behavior to this weight gain is poorly understood.<h4>Methods</h4>The Population Effectiveness of Dolutegravir Implementation in sub-Saharan Africa (DISCO Study) was a prospective observational cohort study that followed participants in KwaZulu-Natal, South Africa, transitioning to TLD. Our primary outcome of interest was clinically significant weight gain, defined as ≥10% increase from baseline to 48 weeks. Primary exposures of interest were (1) fruit intake (servings/week), (2) vegetable intake (servings/week), (3) fast food intake frequency, (4) fried food intake frequency, (5) sugar-sweetened beverage (SSB) intake frequency, and (6","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Dec","modification":"2026-07-16T14:46:20.103Z","creation":"2026-07-09T11:01:08.519Z"},"accession":"S-EPMC12924645","cross_references":{"pubmed":["41329528"],"doi":["10.1097/qai.0000000000003812","10.1097/QAI.0000000000003812"]}}